Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study. [electronic resource]
- Journal of thrombosis and haemostasis : JTH Jun 2011
- 1264-6 p. digital
Publication Type: Clinical Trial; Letter; Multicenter Study
1538-7836
10.1111/j.1538-7836.2011.04281.x doi
Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Factor XIII Factor XIII Deficiency--congenital Female Fibrinolysin--therapeutic use Fibrinolytic Agents Humans Infant Male Middle Aged Young Adult